rs115603533 - LINC02125
Magnitude 2.2 · 1 study on file
Reported associations
-
Genome Wide Association Study of Neuropathic Ocular Pain - Unknown journal (n.d.) · Unknown authors · PubMed 37868788
ABSTRACT: Purpose To conduct a genome-wide association study (GWAS) of individuals with neuropathic ocular pain (NOP) symptoms to identify genomic variants that may predispose to NOP development. Design Prospective study of individuals with NOP. Participants Three hundred twenty-nine patients recruited from the Miami Veterans Affairs eye clinic. Methods The Neuropathic Pain Symptom Inventory modified for the eye (NPSI-Eye) was completed to calculate a NPSI-Eye-Sub-Score (summed ratings of burning and wind sensitivity) as an indicator of NOP severity. A GWAS was performed for the NPSI-Eye-Sub-Score with a significance threshold of P < 5 × 10−8. A gene-based analysis was performed using the multimarker analysis of genomic annotation software (in the functional mapping and annotation of
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Screening
-
neuropathic ocular pain assessment Moderate
rs115603533 in LINC02125 is associated with increased neuropathic ocular pain risk; genetic predisposition warrants heightened clinical attention to eye pain symptoms.
Discuss eye pain or dryness symptoms with ophthalmologist; consider formal neuropathic ocular pain assessment if symptoms present